Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review.

Front Immunol · 2024 · PMC11586331 · PMID 39588371

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Although adjuvant HAIC (HR: 0.57; 95% CI: 0.31, 1.04) and adjuvant sintilimab (HR: 0.51; 95% CI: 0.25, 1.01) did not reach statistical significance, they still showed a favorable trend.

also in 714 other papers

did not reach statistical significanceno p-value reported

Although adjuvant HAIC (HR: 0.57; 95% CI: 0.31, 1.04) and adjuvant sintilimab (HR: 0.51; 95% CI: 0.25, 1.01) did not reach statistical significance, they still showed a favorable trend.

also in 50,127 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.